PHARMOCANN GLOBAL financial statements, including revenue, expenses, profit, and loss

The total revenue of PMCN-M for the last semiannual is 2.30 M ILS, and it's 70.40% lower compared to the previous semiannual. The net income of H1 24 is -1.45 M ILS.